Staging of Schizophrenia with the Use of PANSS: An International Multi-Center Study
Konstantinos N Fountoulakis; Elena Dragioti; Antonis T Theofilidis; Tobias Wikilund; Xenofon Atmatzidis; Ioannis Nimatoudis; Erik Thys; Martien Wampers; Luchezar Hranov; Trayana Hristova; Daniil Aptalidis; Roumen Milev; Felicia Iftene; Filip Spaniel; Pavel Knytl; Petra Furstova; Tiina From; Henry Karlsson; Maija Walta; Raimo K R Salokangas; Jean-Michel Azorin; Justine Bouniard; Julie Montant; Georg Juckel; Ida S Haussleiter; Athanasios Douzenis; Ioannis Michopoulos; Panagiotis Ferentinos; Nikolaos Smyrnis; Leonidas Mantonakis; Zsófia Nemes; Xenia Gonda; Dora Vajda; Anita Juhasz; Amresh Shrivastava; John Waddington; Maurizio Pompili; Anna Comparelli; Valentina Corigliano; Elmars Rancans; Alvydas Navickas; Jan Hilbig; Laurynas Bukelskis; Lidija Injac Stevovic; Sanja Vodopic; Oluyomi Esan; Oluremi Oladele; Christopher Osunbote; Janusz Κ Rybakowski; Pawel Wojciak; Klaudia Domowicz; Maria Luisa Figueira; Ludgero Linhares; Joana Crawford; Anca-Livia Panfil; Daria Smirnova; Olga Izmailova; Dusica Lecic-Tosevski; Henk Temmingh; Fleur Howells; Julio Bobes; Maria Paz Garcia-Portilla; Leticia García-Alvarez; Gamze Erzin; Hasan Karadağ; Avinash De Sousa; Anuja Bendre; Cyril Hoschl; Cristina Bredicean; Ion Papava; Olivera Vukovic; Bojana Pejuskovic; Vincent Russell; Loukas Athanasiadis; Anastasia Konsta; Dan Stein; Michael Berk; Olivia Dean; Rajiv Tandon; Siegfried Kasper; Marc De Hert
Staging of Schizophrenia with the Use of PANSS: An International Multi-Center Study
Konstantinos N Fountoulakis
Elena Dragioti
Antonis T Theofilidis
Tobias Wikilund
Xenofon Atmatzidis
Ioannis Nimatoudis
Erik Thys
Martien Wampers
Luchezar Hranov
Trayana Hristova
Daniil Aptalidis
Roumen Milev
Felicia Iftene
Filip Spaniel
Pavel Knytl
Petra Furstova
Tiina From
Henry Karlsson
Maija Walta
Raimo K R Salokangas
Jean-Michel Azorin
Justine Bouniard
Julie Montant
Georg Juckel
Ida S Haussleiter
Athanasios Douzenis
Ioannis Michopoulos
Panagiotis Ferentinos
Nikolaos Smyrnis
Leonidas Mantonakis
Zsófia Nemes
Xenia Gonda
Dora Vajda
Anita Juhasz
Amresh Shrivastava
John Waddington
Maurizio Pompili
Anna Comparelli
Valentina Corigliano
Elmars Rancans
Alvydas Navickas
Jan Hilbig
Laurynas Bukelskis
Lidija Injac Stevovic
Sanja Vodopic
Oluyomi Esan
Oluremi Oladele
Christopher Osunbote
Janusz Κ Rybakowski
Pawel Wojciak
Klaudia Domowicz
Maria Luisa Figueira
Ludgero Linhares
Joana Crawford
Anca-Livia Panfil
Daria Smirnova
Olga Izmailova
Dusica Lecic-Tosevski
Henk Temmingh
Fleur Howells
Julio Bobes
Maria Paz Garcia-Portilla
Leticia García-Alvarez
Gamze Erzin
Hasan Karadağ
Avinash De Sousa
Anuja Bendre
Cyril Hoschl
Cristina Bredicean
Ion Papava
Olivera Vukovic
Bojana Pejuskovic
Vincent Russell
Loukas Athanasiadis
Anastasia Konsta
Dan Stein
Michael Berk
Olivia Dean
Rajiv Tandon
Siegfried Kasper
Marc De Hert
Oxford University Press
Julkaisun pysyvä osoite on:
https://urn.fi/URN:NBN:fi-fe2021042825441
https://urn.fi/URN:NBN:fi-fe2021042825441
Tiivistelmä
Introduction: A specific clinically relevant staging model for schizophrenia has not yet been developed. The aim of the current study was to evaluate the factor structure of the PANSS and develop such a staging method.
Methods: Twenty-nine centers from 25 countries contributed 2358 patients aged 37.21 ± 11.87 years with schizophrenia. Analysis of covariance, Exploratory Factor Analysis, Discriminant Function Analysis, and inspection of resultant plots were performed.
Results: Exploratory Factor Analysis returned 5 factors explaining 59% of the variance (positive, negative, excitement/hostility, depression/anxiety, and neurocognition). The staging model included 4 main stages with substages that were predominantly characterized by a single domain of symptoms (stage 1: positive; stages 2a and 2b: excitement/hostility; stage 3a and 3b: depression/anxiety; stage 4a and 4b: neurocognition). There were no differences between sexes. The Discriminant Function Analysis developed an algorithm that correctly classified >85% of patients.
Discussion: This study elaborates a 5-factor solution and a clinical staging method for patients with schizophrenia. It is the largest study to address these issues among patients who are more likely to remain affiliated with mental health services for prolonged periods of time.
Methods: Twenty-nine centers from 25 countries contributed 2358 patients aged 37.21 ± 11.87 years with schizophrenia. Analysis of covariance, Exploratory Factor Analysis, Discriminant Function Analysis, and inspection of resultant plots were performed.
Results: Exploratory Factor Analysis returned 5 factors explaining 59% of the variance (positive, negative, excitement/hostility, depression/anxiety, and neurocognition). The staging model included 4 main stages with substages that were predominantly characterized by a single domain of symptoms (stage 1: positive; stages 2a and 2b: excitement/hostility; stage 3a and 3b: depression/anxiety; stage 4a and 4b: neurocognition). There were no differences between sexes. The Discriminant Function Analysis developed an algorithm that correctly classified >85% of patients.
Discussion: This study elaborates a 5-factor solution and a clinical staging method for patients with schizophrenia. It is the largest study to address these issues among patients who are more likely to remain affiliated with mental health services for prolonged periods of time.
Kokoelmat
- Rinnakkaistallenteet [27094]